Source news

dow-jones News

20 stories
EZL BMO
dow-jones

BMO to Buy Euroz Hartleys Group's Australian Capital-Markets Business

By Elias SchisgallBMO Financial Group agreed to acquire Euroz Hartleys Group's Australia-based capital-markets business.The Montreal bank said Euroz Hartleys Group's private-wealth business would enter into a strategic alliance agreement with BMO as an independent entity to maintain its relationshi…

Dow Jones Newswires en
StocksAU
ARQT
dow-jones

Arcutis Biotherapeutics' Psoriasis Cream Gets FDA Approval for Young Children

By Elias SchisgallThe Food and Drug Administration approved the use of Arcutis Biotherapeutics' Zoryve plaque psoriasis cream for children as young as age two.The company on Monday said the FDA approved a supplemental New Drug Application to expand the indication for the 0.3% Zoryve cream. It had p…

Dow Jones Newswires en
StocksUS
ARQT
dow-jones

Arcutis Biotherapeutics' Psoriasis Cream Gets FDA Approval for Young Children

By Elias SchisgallThe Food and Drug Administration approved the use of Arcutis Biotherapeutics' Zoryve plaque psoriasis cream for children as young as age two.The company on Monday said the FDA approved a supplemental New Drug Application to expand the indication for the 0.3% Zoryve cream. It had p…

Dow Jones Newswires en
StocksUS
CNXC
dow-jones

Concentrix Shares Slide on Lowered FY Outlook, Tepid 3Q Guidance — Update

By Elias SchisgallShares of Concentrix slid after the company cut its full-year outlook and projected third-quarter results behind Wall Street's expectations.Shares were down 23% to $19.47 in after-hours trading on Monday. The stock closed up 0.9% at $25.23, down 39% this year.The customer-experien…

Dow Jones Newswires en
StocksUS
DJI GOOG IXIC
dow-jones

Dow Hits Record as Tech Starts Week Strong — WSJ

By Heather Gillers and Rebecca FengThe Dow Jones Industrial Average topped 52000 for the first time on Monday, highlighting investors' increasing demand for stocks at the heart of the American economy.One major contributor was Alphabet, which rose 4.8% to lead gains on the Google-parent's first day…

Dow Jones Newswires en
indexStocksUS
NEU
dow-jones

Neuren Pharmaceuticals's Earnings Boosted by EU U-Turn on Trofinetide — Market Talk

Macquarie upgrades its earnings view for Neuren Pharmaceuticals after a key European regulator changed its mind on the registration of the trofinetide treatment for Rett Syndrome. Its EPS forecasts rise by 5% in each of FY27 and FY28. That's driven by an expected US$35 million milestone payment in…

Dow Jones Newswires en
ETFsStocksAU